Abstract
INTRODUCTION
G laucoma refers to a complex multivariate ocular disease, considered as a degenerative and progressive optic neuropathy that causes damage to the optic nerve and retinal ganglion cells (RGCs) [1] [2] . Recent studies showed the prevalence of glaucoma globally is about 64.3 million, reaching 76.0 million in 2020 and 111.8 million in 2040 [3] .
Consist with the rapid development of the world, the incidence of glaucoma has been increasing continually. Glaucoma is initiated by several risk factors, including increased intraocular pressure, oxidative stress, mitochondrial dysfunction and glutamate neurotoxicity [4] [5] [6] [7] [8] . These factors lead to nerve cells loss, the common pathway for damage of optic nerve and visual field. It is urgent to find more potential injury mechanisms and protective methods because nerve cells are the sole critical output way in the retina [9] . In recent studies, the increased levels of antibodies and activation of glial cells in glaucoma patients, and antibody deposit in the retina revealed the involvement of the immune system in the pathology of glaucoma [10] [11] . Cytokines are synthesized and secreted peptides or glycoproteins which main function is modulating immune reactions, but they can also participate in angiogenesis, cell proliferation and tumor metastasis [12] . Interleukin-8 (IL-8, also called CXCL8), a proinflammatory chemokine, functions as neutrophil chemotaxis and mediates lymphocyte infiltration [13] [14] [15] . It is also closely implicated in both the development and progression of various cancer. Additionally, previous research has shown that IL-8 is toxic to cultured neurons [16] , and increased levels of IL-8 are detected in glaucomatous aqueous humors (AH) and patients with retinal detachment, proliferative vitreous retinopathy and proliferative diabetic retinopathy [17] [18] . IL-8
usually exerts its function via binding to chemokine (C-X-C) receptor1 (CXCR1) and CXCR2, important therapeutic targets in many solid tumors and inflammatory diseases [19] [20] . These receptors have been reported to be expressed in both human and rabbit retina [21] . We have reported before that G31P, an analogue of IL-8, is a selective CXCR1 and CXCR2 antagonist which includes Arg and Pro replacement for Lys11 and Gly31 respectively of human CXCL8 . It has also been shown that G31P can competitively block the binding of ELR-CXC chemokines to both receptors [22] . Based on this background, we chose RGC-5 cells which express tau, βIII-tubulin to simulate neurocyte [23] , evaluated the impact of IL-8 on neural cells and whether the antagonist G31P can attenuate its effect, in order to explore alternative therapy in glaucoma and other nerve diseases.
MATERIALS AND METHODS Main Reagents
The IL-8 used for the study was obtained from Peprotech (American), the culture media; Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM-F12) medium from Gibco, and fetal bovine serum (FBS) from PANBiotech. The RGC-5 cell was purchased from Shanghai Yubo Biological Science and Technology Company. Penicillin/ streptomycin and trypsin were from Transgen (Beijing, China) and Gibco respectively. The antibodies used were mouse anti-β-actin (Bioworld, Beijing, China), mouse anti-Bax and Bcl-2 antibodies (Abcam), and mouse anti-caspase-3 (Cell Signaling Technology). The G31P used was prepared as described previously [22, 24] . Cell Culture RGC-5 was cultured in complete DMEM-F12 medium containing 10% FBS and 1% penicillin/streptomycin at 37℃ in humidified incubator containing 5% CO 2 . The cells were divided into three groups: control, IL-8, and G31P pretreatment. The concentration of G31P used was 100 ng/mL. (Figure 1 ). Following the presence of these receptors, we confirmed IL-8 could promote the expression of CXCR1/2 in RGC-5 cells, and then hypothesized IL-8 antagonists may intercept its associated effects on RGC-5 cells. Subsequently, we assessed the effect of IL-8 on RGC-5 cells viability by using CCK-8 assay. After treatment with different concentrations of IL-8 for 24h, the cell viability was reduced in each group. As shown in Figure 2 , CCK-8 assay revealed that 20 ng/mL IL-8 could cause approximately 50% (51.28%±5.5%, P<0.01) decrease in cell viability compared with untreated control. This concentration used in subsequent treatments throughout the study.
Cell Proliferation Assay

Effect of IL-8 on the Apoptosis in RGC-5
To establish whether IL-8 mediated growth inhibitory activity was associated with apoptosis in RGC-5 cells, we firstly observed changes in the cell nuclei using Hoechst 33258 (Figure 3) . Relatively high numbers of apoptotic cells indicated by condensed and fragmented fluorescent nuclei, were observed in IL-8 treated group. However, the number of apoptotic cells was reduced in G31P pre-treated group, while the control cells exhibited almost no apoptotic nuclei. Additionally, we evaluated the effect of G31P on IL-8 induced cell apoptosis by detecting the apoptotic index using Annexin V-FITC/PI staining and flow cytometry. As shown in Figure 4 , IL-8 increased the number of apoptotic cells from 2.8%±0.20% to 5.62%±0.50% (P<0.01). In the contrast, G31P group decreased the IL-8 induced apoptotic proportion (2.89%±0.45%, P<0.01). These findings suggested that IL-8 has a damage effect on RGC-5 cells and its specific receptor antagonist G31P could alleviate this condition.
Effect of IL-8 on the mRNA and Protein Expression of
Bax, Bcl-2 and Caspase-3 in RGC-5 We next investigated selected apoptotic genes affected by IL-8, focusing on Bax, Bcl-2 and caspase-3. The mRNA expression of these genes were analyzed using RT-PCR techniques, and the variations observed has been presented in Figure 5 . by about five-fold. Additionally, IL-8 treated cells showed a double fold reduction in the anti-apoptotic gene Bcl-2 mRNA level (0.50±0.07, P<0.01). Contrary to these observations, pretreatment with G31P attenuated the IL-8-mediated decrease in Bcl-2 mRNA expression (0.82±0.16, P<0.05). G31P also attenuated the increase in Bax and caspase-3 mRNAs. The expression of these genes were normalized with respect to β-actin. To confirm the translation of these genes, we further determined their protein expressions by Western blot (Figure 6 ). Consistent with the mRNA results, Bax and caspase-3 proteins in RGC-5 cells exposed to IL-8 alone were increased both by about two-fold, and Bcl-2 protein was decreased by twofold. Pre-treatment with G31P attenuated the increase of proapoptotic proteins and enhanced the anti-apoptotic protein expression. These results suggested that G31P intercepts the activation of IL-8 induced apoptosis-related genes. 
Effect of interleukin-8 in RGC-5 cells
DISCUSSION
In this study, for the first time, we demonstrated the specific role of IL-8 on RGC-5 cells survival in vitro. It is well known that IL-8 is an inflammatory chemokine, playing important roles in immune reactions, neutrophil recruitment and tumor growth. But how specific this chemokine affects neuronal ability remains unclear [16] .
Although some previous studies have stated IL-8 protects neurons, elevated levels of this chemokine in the brain are usually linked with negative events [25] [26] , particularly in neuroinflammation resulting from in severe traumatic brain injuries. It has been reported that treatment of cortical neurons with IL-8 induces neuronal cell death [16] . RGCs are typically elongated projections which are susceptible to aging and neurodegenerations [27] , and can't be rejuvenated adequately during optic neuropathies [28] . They play a critical role in transmitting visual information from retina to the brain [27] .
In the present study, we investigated the impact of IL-8 on RGC-5 cells, with some characteristics of RGCs and neural cells which we mostly wanted. The cell viability assay we performed indicated that IL-8 has dose-dependent repressive effects after treated for 24h. Like Alzheimer's disease, glaucoma is increasingly recognized as neurodegenerative disorder, leading to deficient visual function due to the progressive loss of RGCs [29] . Available study suggested RGCs die during normal development and in diseases impacting the optic nerves via a genetically mediated form of cell death called apoptosis [30] . Emerging evidence obtained from some studies indicate chemokine plays important role in the survival of RGCs. An in vitro experiment has revealed that the survival rate of RGCs decreases in a timedependent manner after TNF-α exposure [31] . We observed the condensed and fragmented fluorescent nuclei with Hoechst 33258 fluorescence dye presenting the apoptosis induced by IL-8 treatment. The induction of apoptosis by IL-8 was subsequently confirmed by flow cytometry using Annexin V-FITC/PI kit. The data indicated the apoptotic cells were elevated after exposure to IL-8 for 24h, suggesting that IL-8-caused apoptosis contributes to the viability inhibition of RGC-5 cells. These findings were similar to previous research obtained from cultured neurons [16] . The IL-8 induced apoptosis may occur via a great variety of mechanisms, we therefore chose some classic apoptosisrelated genes including Bcl-2, Bax and caspase-3, and detected their expressions of mRNAs and proteins. It's well known that Bcl-2 has strong antiapoptotic activity in multifarious cells, and Bax, structurally related to Bcl-2, has the contrary function of promoting cell death [30, 32] . Caspase-3, a member of the cysteine-aspartic acid protease (caspase) family, is essential in the execution-phase of cell apoptosis [33] . Our finding established that IL-8-induces RGC-5 apoptosis by reducing the level of Bcl-2, and enhancing the levels of Bax and caspase-3. The action of IL-8 is always mediated by the activation of its high-affinity receptors, CXCR1 and CXCR2 [34] . Previous research reported the presence of CXCR1 and CXCR2 in neurons and glial cells in the retinas of both human and rabbit. Additionally, CXCR1 and CXCR2 immunoreactions were observed in the nerve fibers of ganglion cells and somata respectively. Moreover, the expression of theses receptors in cultured Müller and glial cells of proliferative vitreoretinopathy suggests an involvement of them in the process of gliosis [21] . We examined the expression of CXCR1 and CXCR2 in RGC-5 cells by RT-PCR. Consistently, RGC-5 cells express both receptors under normal condition. At the same time, we found increased levels of CXCR1 and CXCR2 mRNAs after exposure of IL-8, indicating possible pathological functions of these receptors beyond their well-known role in inflammatory procedure. Numerous studies have demonstrated the upregulation of IL-8 under suboptimal oxygenation conditions [35] [36] , in patients retinas with proliferative vitreoretinopathy or proliferative diabetic retinopathy [17, 37] . Clinically, IL-8 has been reported to significantly increased in the aqueous humor of pseudophakic glaucomatous eyes and turns to increase with aging [38] . Reseacher found that the concentration of IL-8 was elevated in aqueous humor of glaucomatous eyes eyes [18] , especially in asymmetric glaucoma patients with severe visual field defects. Similarly, the report of a positive correlation between IL-8 and intraocular pressure suggests the effect of IL-8 in the active regulation of aqueous humor outflow resistance [24] . Moreover, it has been suggested that IL-8 could be produced by ocular tissue [18] . Strategies to block/neutralize IL-8 may be a vital therapeutic mechanism for optic neuropathies. G31P is an engineered analogue of CXCL8, which effectively antagonizes ELR-CXC chemokines and possesses higher binding affinity for CXCR1 and CXCR2 [39] . Our findings demonstrate that pretreatment with G31P attenuates the apoptotic effect of IL-8. Additionally, G31P increased the expression of anti-apoptotic gene Bcl-2 and downregulated the expression of pro-apoptotic genes Bax and caspase-3. In summary, this report demonstrates that IL-8 is detrimental to RGC-5 cells in vitro via regulating the expression of apoptotic genes and binding with CXCR1/2, but pre-treatment with G31P could attenuate its damaging effect. In view of the fact that RGC-5 cells do not fully simulate RGCs in vivo, we need to further clarify and study the toxicity of IL-8 in vivo with better model. However, this study provides a novel molecular research approach for nerve cell injury. By exploring the potential risk factors to neurocytes survival, the results of our study may provide original therapeutic target for protecting neurons and preventing further visual ability loss. At the same time, we couldn't ignore the role of IL-8 in other ocular and neurodegenerative diseases.
